InsidersTradesSigma
Follow the Immatics N.V. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 27 August 2026 (Acquisition). Among the most active insiders: PERCEPTIVE ADVISORS LLC. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Immatics N.V. is a biopharmaceutical company focused on developing therapies based on tumor targets. It specializes in innovation in cancer treatment using advanced technologies.